GraniteShares YieldBoost HIMS ETF(HMYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HMYY GraniteShares YieldBoost HIMS ETF

Pre-Mkt 10-27 04:19:56 EDT

5.13

+0.01

+0.20%

盘前5.43

+0.30+5.85%

04:17 EDT

High5.17	Low5.10	Vol7.81K
Open5.16	D1 Closing5.12	Amplitude1.35%
Mkt Cap872.11K	Tradable Cap872.11K	Total Shares170.00K
T/O40.01K	T/O Rate4.59%	Tradable Shares170.00K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HMYY","market":"US","secType":"STK","nameCN":"GraniteShares YieldBoost HIMS ETF","latestPrice":5.13,"timestamp":1793044800000,"preClose":5.12,"halted":0,"volume":7807,"hourTrading":{"tag":"盘前","latestPrice":5.43,"preClose":5.13,"latestTime":"04:17 EDT","volume":18,"amount":100.880001,"timestamp":1793089072718,"change":0.3,"changeRate":0.05848,"amplitude":0.138402},"delay":0,"changeRate":0.0019531249999999584,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"10-27 04:19:56 EDT","open":5.16,"high":5.169,"low":5.1,"amount":40007.119833000004,"amplitude":0.013477,"askPrice":5.42,"askSize":12100,"bidPrice":4.58,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793107800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":5.13,"sharesOutstanding":110001,"nav":5.118204,"aum":870099.769304,"dividendRate":1.780916,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":5.43,"preClose":5.13,"latestTime":"04:17 EDT","volume":18,"amount":100.880001,"timestamp":1793089072718,"change":0.3,"changeRate":0.05848,"amplitude":0.138402},"postHourTrading":{"tag":"盘后","latestPrice":5.169,"preClose":5.13,"latestTime":"19:49 EDT","volume":13,"amount":66.57,"timestamp":1793058550038,"change":0.039,"changeRate":0.007602,"amplitude":0},"volumeRatio":1.409053},"requestUrl":"/m/hq/s/HMYY/tweets","defaultTab":"tweets","newsList":[{"id":"1121911753","title":"Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=1121911753","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121911753?lang=en_us&edition=fundamental","pubTime":"2026-10-24 12:44","pubTimestamp":1792817070,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4180.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/4180.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","HIYY","MDLN","NVO","NVOC","PFE","LLYX","UN","LLY","LLII","JNJ","UNHW","SNY","HIMS","SYK","ABBV","RXRX","MRNY","MRNA","ELIL","NVOH","BMY","ELIS","UNHG","HMYY","MRNX","HIMZ","NVOX","HIMC","MRK","UNHU","UNH","AMGN"],"isVideo":true,"video":{"duration":176,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/4180/render_4180_1792816267051.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4180.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/4180/tts/voiceover_e20846a625c17310c3dc5a81.mp3","isAI":true},"gpt_icon":0},{"id":"2677947973","title":"Hims & Hers Slips Ahead of White House Meeting on Peptide Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2677947973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677947973?lang=en_us&edition=fundamental","pubTime":"2026-10-23 22:44","pubTimestamp":1792766654,"startTime":"0","endTime":"0","summary":"BUZZ-Hims & Hers slips ahead of White House meeting on peptide policy** Shares of telehealth firm Hims & Hers HealthHIMS.Nfall 4.5% to $27.82, ahead of a White House review meeting on peptide compounding policies today** The meeting, requested by Hims & Hers Health, is set for 2:00 pm ET on Oct 23, as per the Office of Information and Regulatory Affairs' website** Last week, the US FDAsubmitteda proposed policy change to the White House for review that could make it easier for pharmacies to compound certain peptides** HIMS previously said it plans to offerpeptides if regulations permit**Earlier this week, US Health Secretary Robert F. Kennedy Jr. said the administration aims to expand access to peptides by creating a regulated marketplace** As of last close, stock down ~14% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nL4N4691AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMC","THNR","HEAL","HIMZ","BK4196","HIMY","HMYY","HIYY","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677942622","title":"Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint","url":"https://stock-news.laohu8.com/highlight/detail?id=2677942622","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677942622?lang=en_us&edition=fundamental","pubTime":"2026-10-23 17:01","pubTimestamp":1792746062,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) asked a federal judge in California to toss out a Federal Trade Commission complaint that alleged the company misled buyers about products, billed for unwanted subscriptions,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THNR","HIMY","HIMZ","HIYY","HMYY","GLAM","BK4196","HIMS","HIMC","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940645","title":"Hims & Hers Health Shares Slid Even Though Sales Rose","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940645","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677940645?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:34","pubTimestamp":1792744465,"startTime":"0","endTime":"0","summary":"Hims & Hers Health looked like a growth story, with fresh deals in GLP-1s, peptide plans and global expansion splashed across headlines. Investors who held Hims & Hers Health over the past year are down 39.9%, including dividends. That backward step came even as revenue in Q2 2026 was higher and subscriber numbers were rising, while net income swung to a loss. If you had locked in a position a year ago, what early clues pointed to that disconnect?\nHims & Hers Health is not the only name tied...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-shares-slid-even-though-sales-rose","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-shares-slid-even-though-sales-rose","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMC","HIMY","BK4196","HIMS","HMYY","THNR","HIYY","GLAM","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677967184","title":"Hims & Hers Health Expands Testosterone Care with Injectable and Oral TRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2677967184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677967184?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:33","pubTimestamp":1792586016,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRTOct 21 (Reuters)-Hims & Hers Health, Inc.HIMS.N:HIMS EXPANDS TESTOSTERONE CARE WITH INJECTABLE AND ORAL TRTTESTOSTERONE O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN46714J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMC","GLAM","HIMY","THNR","HMYY","HIMS","BK4196","HEAL","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677799026","title":"Hims & Hers Health Inc: Hims Expands Testosterone Care with Injectable and Oral Trt","url":"https://stock-news.laohu8.com/highlight/detail?id=2677799026","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677799026?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:21","pubTimestamp":1792585272,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN46714J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HIMY","THNR","HEAL","BK4196","HIMS","GLAM","HIYY","HIMZ","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677679901","title":"Hims & Hers Health - Testosterone Offering Scaling Rapidly as of Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677679901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677679901?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:21","pubTimestamp":1792585272,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN46714J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","HIMC","HIMZ","HIYY","HEAL","HIMY","GLAM","HIMS","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677679143","title":"Hims & Hers Health - Provides Three New Testosterone Treatment Options Starting Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2677679143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677679143?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:21","pubTimestamp":1792585272,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN46714J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HMYY","THNR","HIMS","HIMZ","BK4196","HIMY","HEAL","GLAM","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677679117","title":"Hims & Hers Health - Launches Twice-Weekly Subcutaneous Injection for Testosterone Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2677679117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677679117?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:21","pubTimestamp":1792585272,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nFWN46714J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HIMZ","HMYY","HEAL","HIMC","HIMY","HIYY","HIMS","THNR","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676926216","title":"Moderately bullish activity in Hims and Hers Health with shares up 4.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676926216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676926216?lang=en_us&edition=fundamental","pubTime":"2026-10-20 22:35","pubTimestamp":1792506916,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $1.22, or 4.33%, near $29.37. Options volume relatively light with 12k c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-4-33-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-4-33-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HIMS","BK4196","HIYY","HIMC","GLAM","HMYY","HEAL","HIMZ","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676695541","title":"Hims & Hers Health Inc: Introducing Hims in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2676695541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676695541?lang=en_us&edition=fundamental","pubTime":"2026-10-20 20:32","pubTimestamp":1792499562,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nFWN4660ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMC","HIMY","HMYY","THNR","HIYY","BK4196","HIMZ","HIMS","GLAM","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676263385","title":"Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676263385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676263385?lang=en_us&edition=fundamental","pubTime":"2026-10-20 02:20","pubTimestamp":1792434012,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Hims and Hers Health (HIMS), with shares up 9c, or 0.32%, near $28.16. Options volume relatively light w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-up-0-32-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-up-0-32-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","HIMS","HIYY","HEAL","HIMZ","HMYY","BK4196","HIMC","HIMY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676546230","title":"Is Peptide Compounding Review Altering The Investment Case For Hims Shares (HIMS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2676546230","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676546230?lang=en_us&edition=fundamental","pubTime":"2026-10-17 13:37","pubTimestamp":1792215449,"startTime":"0","endTime":"0","summary":"Hims & Hers Health has broadened its telehealth footprint with Hers Hair launching in the UK and the Hers platform entering Australia, while also adding an experienced Chief Accounting Officer to support its expanding operations.\nThe business has been preparing for potential regulatory easing on peptide compounding by acquiring a peptide facility and starting ingredient testing, which directly links recent policy headlines to its vertically integrated care model.\nWe will examine how Hims &...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-peptide-compounding-review-altering-the-investment-case-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-peptide-compounding-review-altering-the-investment-case-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIYY","HIMS","BK4196","HIMY","GLAM","HIMC","THNR","HIMZ","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129934572","title":"From $29 To Over $200: Has Moderna Become Dangerously Overvalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=1129934572","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129934572?lang=en_us&edition=fundamental","pubTime":"2026-10-17 13:12","pubTimestamp":1792213939,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3773.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3773.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From $29 To Over $200: Has Moderna Become Dangerously Overvalued?","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMC","RXRX","NVO","MRNX","PFE","UN","GS","AMGN","C","HIYY","UNHG","HMYY","MDLN","XBI","LLII","LLYX","SYK","AZN","MRNA","BMY","NVOC","UNHU","ABBV","UNH","NVOX","BNTX","SNY","MS","ELIS","MRK","HIMZ","NVOH","MRNY","HIMS","JNJ","IBB","UNHW","ELIL","LLY"],"isVideo":true,"video":{"duration":134,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3773.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3773.webp","audio_url":"https://static.tigerbbs.com/7daf6b728543eb1f9121517c9b6c75cc.mp3","isAI":true},"gpt_icon":0},{"id":"2675567738","title":"Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675567738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675567738?lang=en_us&edition=fundamental","pubTime":"2026-10-16 17:00","pubTimestamp":1792141217,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Labcorp Holdings (LH) and Hims & Hers Health (HIMS). Labcorp Hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","HIMZ","LU0006061336.USD","LU0251131958.USD","HIYY","GLAM","LU0251142724.SGD","BK4196","LU0048573561.USD","HMYY","BK4550","HIMS","HIMC","THNR","HIMY","LU1059921491.USD","BK4588","LU0742534661.SGD","BK4585","LH","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675530286","title":"Hims & Hers Health Chief Legal Officer Soleil Boughton Sells $100,576.66 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2675530286","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675530286?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:45","pubTimestamp":1792097141,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Chief Legal Officer Soleil Boughton Sells $100,576.66 in Common SharesHims & Hers Health Chief Legal Officer Soleil Boughton sold 3,461 Class A Common Stock shares on Oct. 14, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL1y9q6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Chief Legal Officer Soleil Boughton Sells $100,576.66 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","THNR","BK4196","GLAM","HIYY","HIMC","HIMY","HIMZ","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675530400","title":"Hims & Hers Health Files Initial Beneficial Ownership Statement for Chief Accounting Officer Jonathan M Franklin","url":"https://stock-news.laohu8.com/highlight/detail?id=2675530400","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675530400?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:45","pubTimestamp":1792097129,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Files Initial Beneficial Ownership Statement for Chief Accounting Officer Jonathan M FranklinHims & Hers Health Chief Accounting Officer Jonathan M Franklin filed an initial stateme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL84GQLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMY","HMYY","HIMZ","HIYY","THNR","HIMC","BK4196","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675172535","title":"Moderately bullish activity in Hims and Hers Health with shares down 2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675172535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675172535?lang=en_us&edition=fundamental","pubTime":"2026-10-15 22:50","pubTimestamp":1792075816,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares down 68c near $27.04. Options volume running well above average with 40k co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-down-2-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-down-2-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMC","HEAL","HIMY","BK4196","HIMS","HMYY","THNR","HIYY","GLAM","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675035173","title":"Hims & Hers Health (HIMS), Why Is Fresh Attention Building Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675035173","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675035173?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:31","pubTimestamp":1791891079,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth.\nFor context, Hims & Hers Health shares now trade at US$30.64, and while the 30 day share price return of 11.38% and 7 day gain of 3.27% point to rebuilding momentum, the stock is still down over the past quarter and year to date, with a 1 year total shareholder return that has declined 44.02%...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["THNR","HIMC","HIMZ","HIYY","HEAL","HIMY","GLAM","HIMS","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807098","title":"Hims & Hers Health Launches Women's Health Platform in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807098","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807098?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:13","pubTimestamp":1791835997,"startTime":"0","endTime":"0","summary":"Hims & Hers Health  said Monday it has launched its Hers women's health platform in Australia, rebranding its existing Juniper service and expanding treatment offerings across hair regrowth, menopause and perimenopause, and weight management.The platform offers access to medication, nutrition and fitness support, and a care team available around the clock.The company said the launch follows its acquisition of Australian digital health company Eucalyptus earlier this year.Existing Juniper patients will continue receiving care from the same team and Australian practitioners, with access to a broader range of specialties, Hims & Hers said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLAM","HIMY","THNR","BK4196","HEAL","HIMC","HMYY","HIMZ","HIYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0106},{"period":"1month","weight":-0.0518},{"period":"3month","weight":-0.1785},{"period":"6month","weight":-0.3133},{"period":"1year","weight":-0.7942},{"period":"ytd","weight":-0.7271}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.1301},{"period":"ytd","weight":0.1224}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"GraniteShares YieldBoost HIMS ETF","nameEN":"GraniteShares YieldBoost HIMS ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GraniteShares YieldBoost HIMS ETF(HMYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GraniteShares YieldBoost HIMS ETF(HMYY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GraniteShares YieldBoost HIMS ETF,HMYY,GraniteShares YieldBoost HIMS ETF股票,GraniteShares YieldBoost HIMS ETF股票老虎,GraniteShares YieldBoost HIMS ETF股票老虎国际,GraniteShares YieldBoost HIMS ETF行情,GraniteShares YieldBoost HIMS ETF股票行情,GraniteShares YieldBoost HIMS ETF股价,GraniteShares YieldBoost HIMS ETF股市,GraniteShares YieldBoost HIMS ETF股票价格,GraniteShares YieldBoost HIMS ETF股票交易,GraniteShares YieldBoost HIMS ETF股票购买,GraniteShares YieldBoost HIMS ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GraniteShares YieldBoost HIMS ETF(HMYY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GraniteShares YieldBoost HIMS ETF(HMYY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}